BAFF/BLyS/TNFSF13B Antibody Summary
Recombinant full length protein (Human).
Type II membrane protein. Also exists as an extracellular soluble form.
BAFF
IgG
Polyclonal
Goat
TNFSF13B
Immunogen affinity purified
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
Applications/Dilutions
- Western Blot 1:100-1:2000
- ELISA 1:100-1:2000
ELISA: Antibody concentration of 0.5 ug/mL (100 uL per well) was usedto detect 0.2 ng/well recombinant BAFFWESTERN BLOT: Antibody concentration of 0.2 ug/mL used to detect 1.5 ng /lane of recombinant BAFF under both reducing and nonreducing conditions.
Reactivity Notes
Cross-reacts with Human. Not yet tested in other species.
Packaging, Storage & Formulations
Store at -20C. Avoid freeze-thaw cycles.
Sterile 10mM PBS (pH 7.4)
No Preservative
Immunogen affinity purified
Alternate Names for BAFF/BLyS/TNFSF13B Antibody
- ApoL related ligand TALL-1
- B lymphocyte stimulator
- BAFF
- BAFFB-cell activating factor
- B-cell-activating factor
- BLyS
- BLYSB-lymphocyte stimulator
- CD257 antigen
- CD257
- Dendritic cell-derived TNF-like molecule
- DTL
- TALL1
- TALL-1delta BAFF
- TALL1Delta4 BAFF
- THANK
- TNF- and APOL-related leukocyte expressed ligand 1
- TNF and ApoL-related leukocyte expressed ligand 1
- TNF homolog that activates apoptosis
- TNFSF13B
- TNFSF20
- tumor necrosis factor (ligand) superfamily, member 13b
- tumor necrosis factor (ligand) superfamily, member 20
- tumor necrosis factor ligand superfamily member 13B
- tumor necrosis factor superfamily, member 13b
- tumor necrosis factor-like protein ZTNF4
- ZTNF4
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
product targets :　Opioid Receptor inhibitors